Crude Oil Plummets! Iran Issues Strong Statement, Pentagon Makes New Move! First Quarter Earnings Preview

First batch of Q1 earnings forecast just released!

U.S. stocks surge, oil prices plummet!

On March 23, international oil prices suddenly dropped sharply. NYMEX WTI crude oil and ICE Brent both fell nearly 10%.

The three major U.S. stock indexes performed strongly, with the Dow Jones up 1.38%, the Nasdaq Composite up 1.38%; the S&P 500 rose 1.15%, the largest single-day gain since February 6.

A50 stock index futures also rose significantly, with an increase of over 1% as of the latest data.

In news, according to CCTV News, on the 23rd, U.S. President Trump posted on social media platform “Real Social” that “the U.S. and Iran have had very good and productive talks over the past two days.”

Trump said he has instructed a five-day pause on all military strikes against Iranian power plants and energy infrastructure, provided ongoing meetings and discussions are successful.

Later, Trump also stated that the U.S. is negotiating with Iran to see if a broader agreement can be reached. He said Iran still has one last chance to end its threats against the U.S… The world will soon become safer.

However, this message was immediately denied by Iran.

According to CCTV News, regarding Trump’s statement that “the U.S. and Iran had very good and effective talks,” Iran’s Fars News Agency, citing sources, reported that “Iran and the U.S. have not communicated directly, nor through mediators.”

Iranian Parliament Speaker Ali Larijani also denied any dialogue with the U.S. on social media. Iranian media, citing sources, said that the claim of a meeting between Iran’s Parliament Speaker Larijani and the U.S. is completely false, and one purpose of fabricating this false news is to create conditions for assassinating Larijani. The sources also said that the false news about negotiations aims to slander Larijani, cause division within Iran, and incite public sentiment.

Israel’s Prime Minister’s Office has not issued any statement regarding Trump’s remarks. In a video speech on the 23rd, Israeli Prime Minister Netanyahu said he had a phone call with President Trump earlier, and Israel will continue airstrikes against Iran and Lebanon.

Meanwhile, regarding the seizure of Halek Island, Xinhua News Agency reported on March 24 that the Pentagon is considering deploying a combat brigade of about 3,000 troops from the 82nd Airborne Division to support military operations against Iran, possibly to seize Iran’s oil export hub, Halek Island.

The report quoted U.S. officials saying that the U.S. military is also considering another plan to seize Halek Island, led by about 2,500 Marines from the 31st Marine Expeditionary Unit heading to the Middle East. After the initial attack on the island, the operation could be taken over and rotated by the 82nd Airborne. The report stated that the Pentagon and U.S. Central Command have not issued any orders regarding the island seizure.

First batch of Q1 earnings forecast just released!

On the evening of March 23, Fuxiang Pharmaceutical released its Q1 2026 performance forecast. The announcement shows that Fuxiang Pharmaceutical achieved a net profit attributable to shareholders of 52 million to 75 million yuan in Q1, a year-on-year increase of 2222.67% to 3250.01%.

Fuxiang Pharmaceutical stated that during the reporting period, benefiting from the continued improvement in the new energy industry, steady growth in the demand for power batteries, and rapid explosion in energy storage battery demand, upstream lithium battery materials demand continued to rise. The company’s lithium battery electrolyte additive business performed well, with core products like VC and FEC increasing in both volume and price, driving a significant year-on-year growth in performance.

According to Securities Times and Data Treasure statistics, as of March 24, 10 A-share listed companies had released their Q1 2026 performance forecasts. Among them, 8 companies forecasted increases or slight increases, 1 turned profitable, and 1 continued to lose money. Based on the median forecast, Haiguang Information, Ailisi, and Wanbangde had net profits exceeding 100 million yuan, at 670 million, 590 million, and 165 million yuan respectively.

Haiguang Information expects Q1 2026 revenue of 3.91 to 4.22 billion yuan, up 62.91% to 75.82% year-on-year; net profit attributable to shareholders of 620 million to 720 million yuan, up 22.56% to 42.32%. Haiguang said that with the rising demand for domestic high-end chips driven by AI industry needs, the market demand continues to climb. The company has increased R&D investment, optimized product performance, and accelerated product iteration, expanding its high-end processor market share and achieving significant revenue growth and sustained performance growth.

Ailisi expects Q1 2026 revenue of 1.55 billion yuan, up 41.12%; net profit attributable to shareholders of 590 million yuan, up 43.73%. Ailisi stated that benefiting from national medical insurance policies and coverage, sales revenue and promotion service income of its commercialized products continued to grow, driving ongoing business performance improvement.

In terms of net profit changes, Fuxiang Pharmaceutical, Wanbangde, Fulihong, Oulide, and Ubox expect their Q1 net profits to double, with increases of 2736.34%, 985.4%, 219.33%, 204.69%, and 102.82%, respectively. Weili expects to turn a profit in Q1.

Wanbangde expects a net profit attributable to shareholders of 165 million yuan in Q1 2026, up 985.4%. The growth is mainly due to the initial success of the company’s strategic shift from generic drugs to innovative drugs, with positive progress in business expansion during the reporting period, creating new growth points, and increased R&D efforts.

Weili expects a net profit attributable to shareholders of 4 to 6 million yuan in Q1 2026, turning profitable from loss. Weili stated that in Q1, the company’s business structure continued to optimize, overall gross profit margin increased. Through prior structural adjustments, personnel optimization, and cost control measures, expenses were further reduced.